These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10027482)

  • 41. Silver acetate mouth spray as an aid in smoking cessation: results of a double-blind trial.
    Morrow R; Nepps P; McIntosh M
    J Am Board Fam Pract; 1993; 6(4):353-7. PubMed ID: 8352038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial.
    Diehl A; Nakovics H; Croissant B; Smolka MN; Batra A; Mann K
    Int J Clin Pharmacol Ther; 2006 Dec; 44(12):614-22. PubMed ID: 17190371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral nicotine solution for smoking cessation: a pilot tolerability study.
    Westman EC; Tomlin KF; Perkins CE; Rose JE
    Nicotine Tob Res; 2001 Nov; 3(4):391-6. PubMed ID: 11694207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Saliva cotinine and recent smoking--evidence for a nonlinear relationship.
    Swan GE; Habina K; Means B; Jobe JB; Esposito JL
    Public Health Rep; 1993; 108(6):779-83. PubMed ID: 8265764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term nicotine substitution after application of a 16-hour nicotine patch in smoking cessation.
    Nørregaard J; Tønnesen P; Simonsen K; Säwe U
    Eur J Clin Pharmacol; 1992; 43(1):57-60. PubMed ID: 1505610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of abstinence from smoking on urinary excretion of hydroxyproline.
    Suchi M; Matsuki H; Misawa K; Kasuga H; Yanagisawa Y
    Tokai J Exp Clin Med; 1989 Dec; 14(5-6):401-7. PubMed ID: 2490269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of cotinine in humans: physiologic, subjective, and cognitive effects.
    Hatsukami DK; Grillo M; Pentel PR; Oncken C; Bliss R
    Pharmacol Biochem Behav; 1997 Aug; 57(4):643-50. PubMed ID: 9258989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers.
    Glassman AH; Covey LS; Dalack GW; Stetner F; Rivelli SK; Fleiss J; Cooper TB
    Clin Pharmacol Ther; 1993 Dec; 54(6):670-9. PubMed ID: 8275622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the nicotine exposure of individual smokers. I. Changes in mouth-level exposure to nicotine on switching to lower nicotine cigarettes.
    Forbes WF; Robinson JC; Hanley JA; Colburn HN
    Int J Addict; 1976; 11(6):933-50. PubMed ID: 1030688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of smoking on the serum ionized magnesium concentration is method-dependent.
    Niemela JE; Cecco SA; Rehak NN; Elin RJ
    Arch Pathol Lab Med; 1997 Oct; 121(10):1087-92. PubMed ID: 9341589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antismoking interventions in residential substance abuse treatment.
    Stack KM; Goalder JS; Calhoun PS; Bradshaw EL; Samples CR
    J Addict Med; 2009 Jun; 3(2):103-8. PubMed ID: 21769005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bromocriptine reduces cigarette smoking.
    Jarvik ME; Caskey NH; Wirshing WC; Madsen DC; Iwamoto-Schaap PN; Elins JL; Eisenberger NI; Olmstead RE
    Addiction; 2000 Aug; 95(8):1173-83. PubMed ID: 11092065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Double-blind study on the influence of difenoxin hydrochloride on intestinal passage time in healthy volunteers (author's transl)].
    Thurnherr N; Spring P
    Arzneimittelforschung; 1979; 29(3):559-62. PubMed ID: 582746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The effect of a beta-adrenergic blocking agent on driving capability (author's transl)].
    Moser L; Schmidt U; Lundt PV
    Med Klin; 1979 Jul; 74(30):1134-9. PubMed ID: 39233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical pharmacological studies with LM 5008, a new antidepressant.
    Iliopoulou A; Kaspi T; Blackett A; Turner P
    Pharmatherapeutica; 1981; 2(9):613-21. PubMed ID: 7267679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A study on urine cotinine for the evaluation of smoking cessation.
    Takeda N; Jitsunari F; Asakawa F; Suna S; Manabe Y; Goda K
    Nihon Eiseigaku Zasshi; 1995 Jun; 50(2):637-51. PubMed ID: 7630032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salivary levels of gramicidin after use of a tyrothricin lozenge and a tyrothricin gargle/mouth-wash.
    Kreuzig F; Nahler G
    Int J Clin Pharmacol Res; 1983; 3(2):65-70. PubMed ID: 6207119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A time series investigation of three nicotine regulation models.
    Velicer WF; Redding CA; Richmond RL; Greeley J; Swift W
    Addict Behav; 1992; 17(4):325-45. PubMed ID: 1502967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Contributions of auriculotherapy in smoking cessation: a pilot study].
    Silva Rde P; Chaves Ede C; Pillon SC; Silva AM; Moreira Dda S; Iunes DH
    Rev Esc Enferm USP; 2014 Oct; 48(5):883-90. PubMed ID: 25493493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cocaine use can increase cigarette smoking: evidence from laboratory and naturalistic settings.
    Roll JM; Higgins ST; Tidey J
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):263-8. PubMed ID: 9260074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.